Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Mutations in RNA splicing factors are the most frequent genetic alterations in myelodysplastic syndrome (MDS).
• These mutations typically occur in a mutually exclusive pattern, but the underlying reasons are unclear.
• Understanding these patterns is crucial for deciphering MDS pathogenesis.

Purpose of the Study:

• To investigate the basis for the mutual exclusivity of spliceosome gene mutations in MDS.
• To elucidate how these mutations contribute to the development of MDS.
• To identify shared functional consequences of different splicing factor mutations.

Main Methods:

• Analysis of co-expression patterns of spliceosome gene mutations in MDS patient data.
• Functional studies assessing the impact of co-expressed mutations on RNA splicing.
• Investigation of downstream effects on hematopoietic stem cell regulators and signaling pathways, including NF-κB.

Main Results:

• Different spliceosome gene mutations have distinct effects on RNA splicing but are negatively selected when co-expressed.
• Co-expression leads to aberrant splicing and downregulation of key regulators of hematopoietic stem cell survival and quiescence, indicating a synthetic lethal interaction.
• Mutations in SF3B1 and SRSF2 converge on aberrant splicing of mRNAs that activate nuclear factor κB (NF-κB) signaling.

Conclusions:

• Spliceosome gene mutations in MDS exhibit a synthetic lethal interaction when co-expressed.
• This interaction contributes to MDS pathogenesis by disrupting hematopoietic stem cell regulation.
• Shared downstream effects on RNA splicing, particularly promoting NF-κB signaling, provide a basis for the observed mutual exclusivity of these mutations.